Edition:
United States

People: CryoLife Inc (CRY.N)

CRY.N on New York Stock Exchange

16.20USD
29 Mar 2017
Change (% chg)

-- (--)
Prev Close
$16.20
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
40,289
52-wk High
$20.10
52-wk Low
$10.64

Capps, Scott 

Mr. Scott B. Capps is Vice President - Clinical Research of the Company. Mr. Capps served as Vice President, General Manager of CryoLife Europa, Ltd. in the U.K. from February 2005 to November 2007 and Director, European Clinical Affairs from April 2003 to January 2005. Mr. Capps joined CryoLife in 1995 as Project Engineer for the allograft heart valve program and was promoted to Director, Clinical Research in 1999. Mr. Capps is responsible for overseeing and implementing clinical trials to achieve FDA and International approval of CryoLife’s medical products in cardiac, vascular, and orthopaedic clinical areas. Before joining CryoLife, Mr. Capps was a Research Assistant in the Department of Bioengineering at Clemson University working to develop a computerized database and radiographic image analysis system for total knee replacement. Mr. Capps received his Bachelor of Industrial Engineering from the Georgia Institute of Technology and his M.S. in Bioengineering from Clemson University.

Basic Compensation

Total Annual Compensation, USD 305,640
Restricted Stock Awards, USD 199,400
Long-Term Incentive Plans, USD --
All Other, USD 107,447
Fiscal Year Total, USD 612,487

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 25,000 37,849.00